mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.6 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |